Key Investor Signals
Secured CHF 40,000 through Venture Kick Stage II
Swiss startup programme Venture Kick awarded CHF 40,000 to advance MONI2 prototypes and algorithms. CHD also signed a convertible loan agreement as part of its Stage II support.
Secured early letters of intent for MONI2
Early engagement with potential customers and partners generated letters of intent and feedback on the belt, app and platform, supporting development of CHD’s home pregnancy-monitoring system.
Signed a maternal-fetal data agreement in Lille
CHD signed an agreement with CIC-IT, the Lille hospital and university research partnership, for anonymized maternal and fetal cardiac signals to develop and validate predictive pregnancy indicators.
Other Positive Signals
- Built an initial proof of concept for collecting maternal and fetal signals during home monitoring.
- Selected for Biopôle’s six-month Vanguard Accelerator for digital health ventures.
Team
Laurent Vandebrouck
CEO
- Spent six years leading Qualcomm Life in Europe, building experience scaling connected-health services across Europe and the US.
- Led Chronolife for five years and another neurotechnology company for 2.5 years, adding repeat CEO experience in connected health.
- Co-founded a digital health media platform and specializes in digital-health platforms and certification of new health indicators.
Fernando Romao
CTO
- Led certification and industrialization of Chronolife’s connected medical T-shirt as VP Engineering.
- Held CTO, product-development and R&D leadership roles across connected devices, consumer electronics and aerospace.
- Trained at CentraleSupélec and ENSAM; works across embedded software, AI, signal processing and RF, with 70+ patents.
Product
MONI2 combines a washable smart-textile belt with a patient app and a clinician web platform. The system under development collects maternal and fetal signals and is intended to support remote assessment of pregnancy risk under clinician supervision.
Abdominal electrical sensing
Dry sensors distributed across the abdomen are designed to collect maternal and fetal ECG signals, contractions and fetal movements. The textile belt is intended for comfortable use during everyday activities.
Separate patient and clinician views
The patient app is designed to provide simplified information, while clinicians access detailed medical data through a secure web platform. Healthcare professionals determine when and how long monitoring should take place.
Predictive pregnancy indicators
Algorithms under development aim to identify warning signs of pregnancy complications, including preterm birth. An agreement with Lille researchers provides access to anonymized maternal and fetal cardiac signals for this work.
Market Overview
Fetal monitoring combines devices, consumables and clinical software sold to hospitals, maternity clinics and other care providers. High-risk pregnancy surveillance requires repeated assessment of fetal well-being, creating demand for connected systems that extend specialist oversight beyond scheduled hospital visits.
Hospitals remain the main buyers of fetal monitoring technology, while home-care applications are a growing segment. Wireless sensing and remote data review can extend existing maternity services into the home. Purchasing decisions include signal reliability, clinical integration and the recurring costs of monitoring.
Estimated global revenue from fetal monitoring instruments and consumables in 2025.
Hospitals are forecast to account for this share of global fetal monitoring revenue in 2026.
Projected annual growth in the global home-care fetal monitoring segment over 2026–2034.
Estimated or provisional number of live births across the European Union in 2024.
Comparable Outcomes
Monica Healthcare
Monica Healthcare developed wireless maternal and fetal monitors. Its Novii patch measures maternal heart rate, fetal heart rate and uterine activity while allowing women to move during labour. GE Healthcare acquired Monica Healthcare in March 2017, following its role as exclusive North American distributor of the Novii Wireless Patch System.
Sense4Baby
Sense4Baby developed a smartphone-based wireless maternal and fetal monitoring system for non-stress testing in high-risk pregnancies. AirStrip acquired Sense4Baby’s assets in March 2014 and separately licensed the associated technology from the West Health Institute.
Interested in More Startups Like CHD?
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.
Sources
This profile was built from public company materials, ecosystem sources, market references, and professional profiles.